Treatment-related improvement in neuropsychological functioning in suicidal depressed patients: paroxetine vs. bupropion.

@article{Gorlyn2015TreatmentrelatedII,
  title={Treatment-related improvement in neuropsychological functioning in suicidal depressed patients: paroxetine vs. bupropion.},
  author={Marianne Gorlyn and John G. Keilp and Ainsley Keller Burke and Maria A. Oquendo and J. John Mann and Michael F Grunebaum},
  journal={Psychiatry research},
  year={2015},
  volume={225 3},
  pages={407-12}
}
Neuropsychological dysfunction is associated with risk for suicidal behavior, but it is unknown if antidepressant medication treatment is effective in reducing this dysfunction, or if specific medications might be more beneficial. A comprehensive neuropsychological battery was administered at baseline and after 8 weeks of treatment within a randomized, double-blind clinical trial comparing paroxetine and bupropion in patients with DSM-IV Major Depressive Disorder and either past suicide attempt… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS